Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1718 studies found for:    bind
Show Display Options
Rank Status Study
1 Active, not recruiting A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: CRPC;   Prostate Cancer
Intervention: Drug: BIND-014
2 Active, not recruiting A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Conditions: Metastatic Cancer;   Cancer;   Solid Tumors
Intervention: Drug: BIND-014
3 Recruiting A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: BIND-014
4 Recruiting Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer
Condition: Uterine Cervical Cancer
Intervention: Drug: albumin-bound paclitaxel plus nedaplatin
5 Active, not recruiting Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: HEAD & NECK Cancer
Intervention: Other: Cetuximab, IMRT, Albumin-bound paclitaxel (Abraxane®)
6 Recruiting Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer
Condition: Gastric Caner
Interventions: Drug: Albumin Bound Paclitaxel;   Drug: 5-FU
7 Recruiting Wheelchair-bound Senior Elastic Band (WSEB) Exercise Program for the Demented Seniors
Condition: Dementia
Intervention: Other: Wheelchair-bound Senior Elastic Band exercise program (WSEB)
8 Recruiting Plasma Protein Binding Characteristics of Voriconazole
Condition: Focus of the Study:Protein Binding Characteristics of Voriconazole.
Intervention: Other: Blood sampling
9 Recruiting A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive Non-Small Cell Lung Cancer
Condition: KRAS Positive Patients With Non-small Cell Lung Cancer
Intervention: Drug: BIND-014 (Docetaxel Nanoparticles for Injectable Suspension)
10 Not yet recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus
Condition: Squamous Cell Carcinoma of Esophagus
Intervention: Drug: nanoparticle albumin-bound paclitaxel
11 Completed Diagnostic Value of Heart-Fatty Acid Binding Protein and Ischemia Modified Albumin as Biochemical Markers on Non ST Segment Elevation Acute Coronary Syndrome at the Emergency Room.
Condition: Acute Coronary Syndrome
Intervention: Other: Measure of Initial heart fatty acid binding protein and ischemia modified albumin
12 Recruiting Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Albumin Bound Paclitaxel;   Drug: S-1
13 Not yet recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel
14 Recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung
Condition: Non-small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel/carboplatin
15 Completed TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: colloidal gold-bound tumor necrosis factor;   Other: pharmacological study
16 Active, not recruiting The Value of HBA in the Evaluation of Idiopathic Infertility
Condition: Infertility
Intervention: Other: HBA binding assay
17 Unknown  Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia
Condition: Myeloid Leukemia
18 Unknown  Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis
Condition: Uremia
Intervention: Procedure: mFPSA treatment
19 Completed Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
Conditions: Hyperlipidemia;   Atherosclerosis
Intervention: Drug: Temporary discontinuation of statin therapy
20 Enrolling by invitation Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: [18F]AV-45 PET amyloid binding imaging

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years